MedPage Today -- A low-dose combination of rosiglitazone (Avandia) and metformin appears to prevent type 2 diabetes in patients with impaired glucose tolerance (IGT), Canadian researchers have found.
MedPage Today -- A low-dose combination of rosiglitazone (Avandia) and metformin appears to prevent type 2 diabetes in patients with impaired glucose tolerance (IGT), Canadian researchers have found.